Family Medicine · Collegeville, PA
NPI
1417937715
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
555 2nd Ave, Suite C300
Collegeville, PA, 19426
Phone (610) 454-7750
Groups this clinician bills Medicare through
Medicare paid, 2024
$196K
5,473 services
Medicare patients, 2024
531
Average age 72
Drug cost, 2024
$1.5M
12,007 prescriptions
Company payments, 2025
$162K
From 41 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul P Doghramji was code J1010 (injection, methylprednisolone acetate, 1 mg), 2,440 times for 28 patients. In total Paul P Doghramji billed 5,473 services in 72 codes, and Medicare paid $196K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,440 | 28 | $0.10 | $242 |
| 99214 Office E&M - Established | Office | 576 | 332 | $89.84 | $52K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 465 | 86 | $46.33 | $22K |
| 99213 Office E&M - Established | Office | 292 | 208 | $64.04 | $19K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 257 | 257 | $19.36 | $4,977 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 249 | 249 | $132.37 | $33K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 149 | 123 | $12.73 | $1,897 |
| G0008 Administration of influenza virus vaccine | Office | 110 | 109 | $29.90 | $3,288 |
| 90662 Vaccine Product | Office | 104 | 103 | $80.68 | $8,391 |
| 99211 Office E&M - Established | Office | 68 | 48 | $16.83 | $1,145 |
| 96372 Injection Administration | Office | 65 | 32 | $10.68 | $694 |
| 87428 Infectious Agent Detection by DNA/RNA | Office | 59 | 54 | $68.88 | $4,064 |
| 99215 Office E&M - Established | Office | 55 | 38 | $131.86 | $7,252 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 38 | 13 | $0.89 | $33.93 |
| 81002 Clinical Chemistry | Office | 38 | 29 | $3.41 | $130 |
By year: 2022 $130K for 1,954 services; 2023 $172K for 2,606 services; 2024 $196K for 5,473 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87428 Infectious Agent Detection by DNA/RNA | 59 | 54 | $68.88 | $4,064 |
| 81002 Clinical Chemistry | 38 | 29 | $3.41 | $130 |
| 80305 Drug Tests | 32 | 32 | $12.04 | $385 |
| 87880 Immunoassay | 12 | 12 | $16.20 | $194 |
Medicare prescription drug claims, 2024
In 2024, the drug Paul P Doghramji prescribed most often to Medicare patients was Atorvastatin Calcium, with 642 prescriptions and refills. In total Paul P Doghramji wrote 12,007 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 642 | 1,781 | 187 | $8,364 |
| Levothyroxine Sodium Generic | 328 | 924 | 104 | $3,753 |
| Pantoprazole Sodium Generic | 301 | 831 | 95 | $4,682 |
| Amlodipine Besylate Generic | 295 | 787 | 86 | $1,444 |
| Rosuvastatin Calcium Generic | 257 | 748 | 91 | $4,268 |
| Oxycodone Hcl Generic | 252 | 252 | 33 | $8,043 |
| Alprazolam Generic | 250 | 273 | 47 | $1,647 |
| Clonazepam Generic | 190 | 220 | 31 | $1,056 |
| Gabapentin Generic | 187 | 300 | 48 | $2,508 |
| Lorazepam Generic | 168 | 191 | 40 | $570 |
| Tramadol Hcl Generic | 161 | 163 | 42 | $1,227 |
| Metformin Hcl Generic | 159 | 438 | 56 | $1,425 |
| Escitalopram Oxalate Generic | 154 | 405 | 55 | $2,285 |
| Metoprolol Succinate Generic | 150 | 400 | 51 | $2,789 |
| Lisinopril Generic | 146 | 392 | 49 | $1,344 |
Brand drugs: 1,676 claims; generic drugs: 10,260 claims; opioid claims: 909.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul P Doghramji $162K ($162K in general payments such as food, travel and fees) from 41 companies. The largest payer was Axsome Therapeutics, Inc. with $57K.
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. AXSM | 84 | $57K |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 55 | $39K |
| Pfizer Inc. PFE | 28 | $14K |
| Otsuka America Pharmaceutical, Inc. 4578.T | 20 | $12K |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 13 | $11K |
| Tonix Medicines, Inc. | 6 | $8,132 |
| AstraZeneca Pharmaceuticals LP AZN | 15 | $4,845 |
| Lilly USA, LLC LLY | 10 | $4,811 |
| Amgen Inc. AMGN | 16 | $4,567 |
| Janssen Global Services, LLC JNJ | 1 | $2,300 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.